Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Accuray stock

ARAY
US0043971052
A0MKWM

Price

0
Today +/-
-0
Today %
-0 %

Accuray stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Accuray stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Accuray stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Accuray stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Accuray's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Accuray Stock Price History

DateAccuray Price
12/3/20240 undefined
12/2/20240 undefined
11/29/20240 undefined
11/27/20240 undefined
11/26/20240 undefined
11/25/20240 undefined
11/22/20240 undefined
11/21/20240 undefined
11/20/20240 undefined
11/19/20240 undefined
11/18/20240 undefined
11/15/20240 undefined
11/14/20240 undefined
11/13/20240 undefined
11/12/20240 undefined
11/11/20240 undefined
11/8/20240 undefined
11/7/20240 undefined
11/6/20240 undefined
11/5/20240 undefined
11/4/20240 undefined

Accuray Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Accuray, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Accuray from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Accuray’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Accuray. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Accuray’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Accuray’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Accuray’s growth potential.

Accuray Revenue, EBIT and net profit per share

DateAccuray RevenueAccuray EBITAccuray Net Income
2027e0 undefined0 undefined0 undefined
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
20240 undefined0 undefined0 undefined
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined

Accuray Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e
000000000000000000000000
------------------------
------------------------
000000000000000000000000
000000000000000000000000
------------------------
000000000000000000000000
------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Accuray Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Accuray is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20052006200720082009201020112012201320142015201620172018201920202021202220232024
                                       
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
                                       
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Accuray provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Accuray's financial health and stability.

Assets

Accuray's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Accuray must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Accuray after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Accuray's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
20042005200620072008200920102011201220132014201520162017201820192020202120222023
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000
--------------------
00000000000000000000
00000000000000000000
00000000000000000000
00000000000000000000

Accuray stock margins

The Accuray margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Accuray. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Accuray.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Accuray's sales revenue. A higher gross margin percentage indicates that the Accuray retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Accuray's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Accuray's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Accuray's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Accuray. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Accuray's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Accuray Margin History

Accuray Gross marginAccuray Profit marginAccuray EBIT marginAccuray Profit margin
2027e0 %0 %0 %
2026e0 %0 %0 %
2025e0 %0 %0 %
20240 %0 %0 %
20230 %0 %0 %
20220 %0 %0 %
20210 %0 %0 %
20200 %0 %0 %
20190 %0 %0 %
20180 %0 %0 %
20170 %0 %0 %
20160 %0 %0 %
20150 %0 %0 %
20140 %0 %0 %
20130 %0 %0 %
20120 %0 %0 %
20110 %0 %0 %
20100 %0 %0 %
20090 %0 %0 %
20080 %0 %0 %
20070 %0 %0 %
20060 %0 %0 %
20050 %0 %0 %

Accuray Stock Sales Revenue, EBIT, Earnings per Share

The Accuray earnings per share therefore indicates how much revenue Accuray has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Accuray earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Accuray's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Accuray’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Accuray's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Accuray Revenue, EBIT and net profit per share

DateAccuray Sales per ShareAccuray EBIT per shareAccuray Earnings per Share
2027e0 undefined0 undefined0 undefined
2026e0 undefined0 undefined0 undefined
2025e0 undefined0 undefined0 undefined
20240 undefined0 undefined0 undefined
20230 undefined0 undefined0 undefined
20220 undefined0 undefined0 undefined
20210 undefined0 undefined0 undefined
20200 undefined0 undefined0 undefined
20190 undefined0 undefined0 undefined
20180 undefined0 undefined0 undefined
20170 undefined0 undefined0 undefined
20160 undefined0 undefined0 undefined
20150 undefined0 undefined0 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined

Accuray business model

Accuray Inc is a company that was founded in 1990 and is headquartered in Sunnyvale, California. It is a global leader in providing precision solutions for the radiation treatment of cancer and other medical conditions. The company aims to develop revolutionary technologies that offer doctors and patients new treatment options for cancer and other diseases. History: Accuray was founded as a start-up company by a group of scientists who believed that cancer treatment was a crucial problem, with a lack of precision and control compromising the effectiveness of treatment. Therefore, they decided to develop a solution focused on precise, non-invasive radiation therapy. Since then, Accuray has continuously developed and introduced innovative technologies to enable better treatment for patients. Business model: Accuray's business model focuses on the development, sale, and service of radiation therapy products and solutions. The company provides global clinical support to ensure that customers receive the best possible application of Accuray technologies. Accuray primarily generates its revenues through the sale of radiation therapy systems and services. The company has over 800 employees worldwide and operates manufacturing locations in the US and China. Products and solutions: Accuray offers a wide range of products and solutions for clinical radiation therapy. These include the TomoTherapy systems, CyberKnife systems, and Radixact systems. The TomoTherapy systems have been specifically designed for precise and patient-specific radiation therapy applications. The technology enables precise dosage of radiation to tumor cells, protecting the surrounding healthy tissues. The CyberKnife system is used for the treatment of tumors that are difficult to access, such as those in the brain or spine. The robotic technology and precise radiation dosage enhance the effectiveness of treatment. With the Radixact system, Accuray offers a system that provides the latest generation of radiation therapy. The system delivers extremely precise dosages to the tumor while maximizing the preservation of surrounding tissues. Divisions: Accuray is divided into three business segments: Oncology Systems, Radiation Therapy Services, and Research Solutions. - Oncology Systems: Accuray offers the aforementioned TomoTherapy, CyberKnife, and Radixact systems, providing customers with the latest technology to treat various types of cancer. - Radiation Therapy Services: Accuray also provides a wide range of service and support offerings for its customers. These services include training, maintenance, technician support, and customer support. - Research Solutions: Accuray's research division provides academic institutions and research laboratories with access to a variety of technologies and solutions for radiation therapy and cancer research. Conclusion: Accuray has tirelessly worked to develop innovative technologies for radiation therapy, enabling better treatment and quality of life for patients. The company has made significant progress in recent years and now offers a wide range of products and solutions to its customers. Accuray has established itself as a global leader in radiation therapy and continues its success story with continuous research and innovation. Answer: Accuray Inc is a company that specializes in providing precision solutions for radiation treatment of cancer and other medical conditions. It was founded in 1990 and is headquartered in Sunnyvale, California. The company aims to develop innovative technologies that offer patients and doctors new treatment possibilities. Accuray has three divisions: Oncology Systems, Radiation Therapy Services, and Research Solutions. Their products include TomoTherapy, CyberKnife, and Radixact systems. Accuray is a leading global provider of radiation therapy solutions and continues to make advancements in research and innovation. Accuray is one of the most popular companies on Eulerpool.com.

Accuray SWOT Analysis

Strengths

Accuray Inc possesses several strengths that contribute to its competitive advantage in the market:

  • Technological Expertise: The company specializes in developing and manufacturing advanced radiation therapy systems, positioning it as an industry leader in this field.
  • Strong Research and Development: Accuray Inc continually invests in R&D to enhance its product portfolio, ensuring it stays at the forefront of innovation.
  • Global Presence: The company has established a strong global presence, allowing it to tap into multiple markets and diversify its revenue streams.
  • Established Brand: Accuray Inc has built a reputable brand, known for delivering high-quality and precise medical solutions.

Weaknesses

Despite its strengths, Accuray Inc faces certain weaknesses that may hinder its growth and profitability:

  • Dependence on a Single Product Line: The company heavily relies on its radiation therapy systems, making it vulnerable to any potential disruptions or shifts in market demand.
  • Limited Market Share: Accuray Inc faces strong competition from larger and more established players in the medical technology industry, which limits its market share.
  • Price Sensitivity: The cost of Accuray Inc's products can be relatively high, making them less accessible to certain markets or healthcare providers with budget constraints.

Opportunities

Accuray Inc can leverage several opportunities to further expand its business and market reach:

  • Growing Demand for Cancer Treatments: The increasing prevalence of cancer globally presents a significant opportunity for Accuray Inc to cater to the rising demand for advanced radiation therapy solutions.
  • Emerging Markets: The company can explore untapped markets in developing countries, where the need for advanced medical technologies is rising.
  • Partnerships and Collaborations: Accuray Inc can form strategic partnerships with leading medical institutions and research centers to enhance its technological capabilities and gain a competitive edge.

Threats

Accuray Inc faces various external threats that may impact its business operations and profitability:

  • Intense Competition: The medical technology industry is highly competitive, with new entrants and established players constantly vying for market share.
  • Regulatory Challenges: The company must comply with strict regulations and certifications to distribute its products globally, which may involve significant costs and delays.
  • Economic Volatility: Any economic downturn or instability in key markets can potentially impact Accuray Inc's sales and revenue growth.

Accuray Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Accuray Revenue by Segment

Segmente20222021202020192018
Services-12.36 M USD215.63 M USD222.12 M USD221 M USD
Products-12.03 M USD167.3 M USD196.67 M USD183.9 M USD
Product45.55 M USD----
Service10.33 M USD----

Accuray Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Accuray Revenue by Segment

DateAmericasAsia excluding Japan and IndiaAsia PacificAsia Pacific excluding Japan and ChinaChinaCHINAJapanJAPANRegions of Europe, India, Middle East and AfricaRegions of Europe, Middle East, India and Africa
2022126.01 M USD--28.95 M USD-86.94 M USD-53.38 M USD134.64 M USD-
2021105.88 M USD--26.43 M USD79.78 M USD-62.64 M USD-121.57 M USD-
2020128.56 M USD61.69 M USD----72.69 M USD-119.99 M USD-
2019135.68 M USD-63.79 M USD---70.21 M USD-149.1 M USD-
2018145.69 M USD-72.93 M USD---66.25 M USD--120.03 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Accuray Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Accuray historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Accuray shares outstanding

The number of shares was Accuray in 2023 — This indicates how many shares 94.9 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Accuray earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Accuray's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Accuray’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Accuray's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Accuray.

Accuray latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20240 0  (25.37 %)2025 Q1
6/30/20240 0  (6.76 %)2024 Q4
3/31/20240 0  (-368.75 %)2024 Q3
12/31/20230 0  (-96.08 %)2024 Q2
9/30/20230 0  (41.18 %)2024 Q1
6/30/20230 0  (-394.12 %)2023 Q4
3/31/20230 0  (184.03 %)2023 Q3
12/31/20220 0  (26.47 %)2023 Q2
9/30/20220 0  (-167.86 %)2023 Q1
6/30/20220 0  (34.85 %)2022 Q4
1
2
3
4
5
...
8

Eulerpool ESG Scorecard© for the Accuray stock

Eulerpool World ESG Rating (EESG©)

38/ 100

🌱 Environment

13

👫 Social

51

🏛️ Governance

51

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Accuray shareholders

%
Name
Stocks
Change
Date
6.70721 % BlackRock Institutional Trust Company, N.A.6,745,43828,9016/30/2024
5.28850 % Neuberger Berman, LLC5,318,644-494,4886/30/2024
5.22979 % The Vanguard Group, Inc.5,259,60012,0446/30/2024
5.11087 % Aevum Fondation de Pr¿voyance5,140,0005,140,0009/30/2024
3.30113 % Heartland Advisors, Inc.3,319,950400,7506/30/2024
2.86620 % Royce Investment Partners2,882,536-391,9236/30/2024
2.79625 % Renaissance Technologies LLC2,812,1847,5006/30/2024
2.12175 % Geode Capital Management, L.L.C.2,133,84852,3606/30/2024
1.83870 % Harbert Fund Advisors, Inc1,849,18406/30/2024
1.81394 % State Street Global Advisors (US)1,824,27917,2366/30/2024
1
2
3
4
5
...
10

Accuray Executives and Management Board

Ms. Suzanne Winter

(60)
Accuray President, Chief Executive Officer, Director (since 2019)
Compensation 2.64 M

Mr. Sandeep Chalke

(56)
Accuray Senior Vice President, Chief Commercial Officer
Compensation 1.35 M

Mr. Jesse Chew

(41)
Accuray Senior Vice President, Chief Legal Officer and Corporate Secretary
Compensation 1.11 M

Mr. Ali Pervaiz

(43)
Accuray Chief Financial Officer, Senior Vice President
Compensation 1.09 M

Mr. Patrick Spine

(52)
Accuray Senior Vice President, Chief Administrative Officer
Compensation 1.08 M
1
2
3

Most common questions regarding Accuray

What values and corporate philosophy does Accuray represent?

Accuray Inc represents values of innovation, precision, and patient-centric care in the field of radiation oncology. With a corporate philosophy focused on improving the lives of cancer patients, Accuray Inc offers cutting-edge solutions like the CyberKnife and Radixact systems. These advanced technologies provide non-invasive and highly accurate treatment options, enabling personalized cancer care and improved quality of life. Accuray Inc aims to empower healthcare professionals with state-of-the-art tools, fostering collaboration and optimal treatment outcomes. As a global leader in radiation therapy, Accuray Inc continues to revolutionize cancer treatment, making a positive impact on patients worldwide.

In which countries and regions is Accuray primarily present?

Accuray Inc is primarily present in several countries and regions across the globe. The company has a strong presence in North America, with operations in the United States and Canada. Additionally, Accuray Inc has expanded its reach to Europe, including countries such as Germany, France, Italy, and the United Kingdom. The company is also present in the Asia-Pacific region, with a significant presence in Japan, China, India, and Australia. Accuray Inc's global presence allows it to cater to a wide range of markets and provide its innovative medical solutions to healthcare professionals worldwide.

What significant milestones has the company Accuray achieved?

Accuray Inc has achieved several significant milestones in its history. One notable achievement is the development and introduction of the CyberKnife System, a robotic radiosurgery system that revolutionized cancer treatment. The company also attained regulatory clearance for its innovative TomoTherapy System, which combines precise radiation therapy with integrated CT imaging. Accuray Inc has expanded its global reach, establishing a presence in over 100 countries worldwide. Moreover, the company has consistently demonstrated a commitment to innovation, investing in research and development to enhance its advanced treatment solutions. These achievements highlight Accuray Inc's dedication to improving cancer care and solidify its position as a leader in the field.

What is the history and background of the company Accuray?

Accuray Inc. is a renowned medical technology company specializing in the development and sale of innovative radiation therapy solutions. Founded in 1990, Accuray is based in Sunnyvale, California. The company's flagship product, the CyberKnife System, is a non-invasive robotic radiosurgery system utilized for treating cancerous and non-cancerous tumors. With a blend of advanced robotics and real-time tumor tracking, Accuray's CyberKnife System enables precise delivery of radiation therapy, minimizing damage to surrounding healthy tissues. Over the years, Accuray has consistently introduced cutting-edge advancements in the field of radiosurgery, revolutionizing the way cancer is treated globally. Accuray's commitment to improving patient outcomes has made it a trusted name in the healthcare industry.

Who are the main competitors of Accuray in the market?

The main competitors of Accuray Inc in the market include Varian Medical Systems, Elekta AB, and ViewRay Inc.

In which industries is Accuray primarily active?

Accuray Inc is primarily active in the medical technology industry.

What is the business model of Accuray?

The business model of Accuray Inc, a leading medical technology company, revolves around providing innovative and precise radiation therapy solutions for the treatment of multiple types of cancer. With their flagship product, the CyberKnife System, Accuray offers non-invasive treatment options that deliver targeted radiation directly to tumors while minimizing damage to surrounding healthy tissues. This state-of-the-art technology enables personalized treatment plans tailored to each patient's unique needs, increasing treatment effectiveness and minimizing side effects. By combining advanced hardware and software solutions, Accuray Inc aims to enhance patient outcomes and improve the quality of life for individuals battling cancer.

What is the P/E ratio of Accuray 2024?

The P/E ratio cannot be calculated for Accuray at the moment.

What is the P/S ratio of Accuray 2024?

The P/S cannot be calculated for Accuray currently.

What is the Quality Investing of Accuray?

The Quality Investing cannot be calculated for Accuray at the moment.

What is the revenue of Accuray 2024?

The revenue cannot currently be calculated for Accuray.

How high is the profit of Accuray 2024?

The profit cannot currently be calculated for Accuray.

What is the business model of Accuray

Accuray Inc is a global manufacturer of medical devices for the radiation therapy treatment of cancer. The company's main products are the CyberKnife and TomoTherapy systems. The company also offers a range of services and support facilities for its devices. In addition, Accuray Inc also provides software solutions for medical imaging and workflow management. The CyberKnife systems by Accuray target tumor and non-tumor areas for precise treatment. This system uses robotic precision and image-guided technology to deliver radiation to the exact location where the tumor is located. This method spares healthy cells and allows for complete recovery. The CyberKnife system is used in diverse treatment areas including brain tumors, liver tumors, spine cancer, and prostate cancer. The TomoTherapy system is a computer-assisted procedure that integrates imaging and radiation planning in one system. The TomoTherapy systems combine continuous, rotating radiation source with precise imaging technology for accuracy and precision in radiation therapy. This system is used for various types of cancer including head and neck cancer, breast cancer, lung cancer, and prostate cancer. Accuray also offers software solutions for medical imaging and workflow management. The iDMS software by Accuray enables healthcare facilities to automatically manage and monitor their session bookings, orders for radiation therapy, and approved quantity. The uMI software allows for easy and effective imaging and radiation planning for the CyberKnife and TomoTherapy systems. The company also operates a clinical services division which provides a variety of management and support services including training, installation, technical support, and system maintenance. Accuray's commitment to customer satisfaction from this division is a crucial part of its business model as these services ensure the long-term safety and efficacy of the systems. Accuray sells its products to leading hospitals and medical centers in the USA, Europe, Asia, and other parts of the world. The company targets customers with a high need for precise radiation therapy, including oncologists, radiation therapists, and other medical professionals. Accuray's business model creates value by providing innovative and effective cancer treatment devices and software solutions. The company also has a high appreciation in the clinical division, which ensures the long-term health of customers. The demand for precise radiation therapy will continue to grow as the cancer rate in the population increases. This makes Accuray's business model sustainable and will continue to expand in the future.

What is the Accuray dividend?

Accuray pays a dividend of 0 USD distributed over payouts per year.

How often does Accuray pay dividends?

The dividend cannot currently be calculated for Accuray or the company does not pay out a dividend.

What is the Accuray ISIN?

The ISIN of Accuray is US0043971052.

What is the Accuray WKN?

The WKN of Accuray is A0MKWM.

What is the Accuray ticker?

The ticker of Accuray is ARAY.

How much dividend does Accuray pay?

Over the past 12 months, Accuray paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Accuray is expected to pay a dividend of 0 USD.

What is the dividend yield of Accuray?

The current dividend yield of Accuray is .

When does Accuray pay dividends?

Accuray pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Accuray?

Accuray paid dividends every year for the past 0 years.

What is the dividend of Accuray?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Accuray located?

Accuray is assigned to the 'Health' sector.

Wann musste ich die Aktien von Accuray kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Accuray from 12/4/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/4/2024.

When did Accuray pay the last dividend?

The last dividend was paid out on 12/4/2024.

What was the dividend of Accuray in the year 2023?

In the year 2023, Accuray distributed 0 USD as dividends.

In which currency does Accuray pay out the dividend?

The dividends of Accuray are distributed in USD.

All fundamentals about Accuray

Our stock analysis for Accuray Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Accuray Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.